Work

Phase I Study of Triciribine Phosphate Monohydrate, a Specific Inhibitor of AKt Phosphorylation, in Adult Patients with Advanced Hematologic Malignancies.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.913.913

Authors: Farhad Ravandi, Jeffrey Lancet, Francis Giles, William Plunkett, Betsy Williams, Michelle Burton, Stefan Faderl, Zeev Estrov, Gautam Borthakur, Lawrence Akinsanmi, Hagop Kantarjian

Institutions: The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, The University of Texas at San Antonio Health Science Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980268771

FWCI: 0.395

Cites:

Cited by: 3

Related to: 10